Nosocomial influenza in patients with cancer before the coronavirus disease 2019 (COVID-19) era and one year after the pandemic: Can we do any better in hospitals?

Abstract

Financial support. This work was supported by a grant (no. CP 10/2019) from the Fundação Araucária and APC.Conflicts of interest. F. F. Tuon is a CNPq researcher. The other authors declare no competing interests.3. Santaniello A, Sansone M, Fioretti A, Menna LF. Systematic review and meta-analysis of the occurrence of ESKAPE bacteria group in dogs, and the related zoonotic risk in animal-assisted therapy, and in animalassisted activity in the health context.

Sharp decline in rates of community respiratory viral detection among patients at the National Institutes of Health Clinical Center during the coronavirus disease 2019 (COVID-19) pandemic

“…Many, if not most, published manuscripts suggest the primary reason for such a decrease relates directly to the implementation of COVID-19 mitigation strategies (Table 3). 3,8,[13][14][15][16][24][25][26][27][28][29][30][31][32][33][34][35][36][37] However, as noted previously, demonstrating the effect of any individual intervention is often challenging. Universal masking represented a major departure from prior infection prevention strategies in our institution that we suspect substantially affected the risk for respiratory virus transmission.…”

“…The COVID-19 pandemic has had a profound impact on society at-large and on medicine and healthcare, specifically. Although healthcare-associated bacterial infections have increased during the pandemic (1,2), one striking pandemic-associated finding was a dramatic decrease in influenza and other respiratory virus infections around the worldboth among the public (3)(4)(5)(6)(7)(8)(9)(10)(11)(12), as well as in healthcare institutions (13)(14)(15)(16).…”

“…Although healthcare-associated bacterial infections have increased during the pandemic, 1,2 one striking pandemic-associated finding was a dramatic decrease in influenza and other respiratory virus infections around the world, both among the public [3][4][5][6][7][8][9][10][11][12] as well as in healthcare institutions. [13][14][15][16] The National Institutes of Health Clinical Center (NIHCC) is a federally funded 200-bed clinical research hospital located in Bethesda, Maryland. NIH investigators recruit patients, who often have rare, unknown, or difficult-to-treat disorders, to participate in clinical research studies.…”